University of Washington Self-Efficacy Scale: A New Self-Efficacy Scale for People With Disabilities
University of Washington Self-Efficacy Scale: A New Self-Efficacy Scale for People With Disabilities
复制标题
DOI：
10.1016/j.apmr.2012.05.001
复制
发表时间：
2012-10-01
影响因子：
4.3
通讯作者：
Brockway, Jo Ann
中科院分区：
文献类型：
--
作者：
Amtmann, Dagmar;Bamer, Alyssa M.;Brockway, Jo Ann
Amtmann D，Bamer AM，Cook KF，Askew RL，Noonan VK，Brockway JA.华盛顿大学自我效能量表：一个新的残疾人自我效能量表。Arch Phys Med Rehabil 2012;93：1757- 65. Objective：To develop a self-efficacy scale for people living with multiple sclerosis（MS）and spinal cord injury（SCI）that can be used across diagnosis conditions.Design：该量表使用现代心理测量学方法包括项目反应理论开发。在MS和SCI个体纵向调查的3个时间点管理项目。设置：MS调查参与者从国家MS协会招募，SCI参与者从西北地区脊髓损伤模型系统和佐治亚州亚特兰大弗吉尼亚克劳福德研究所的Shepherd中心招募。参与者：年龄在18岁及以上的成年人报告MS（N = 473）或SCI（N = 253）的明确诊断。干预措施：无。主要结果指标：对新的自我效能测量方法华盛顿大学自我效能量表（UW-SES）的评估包括与慢性病自我效能量表的比较。Efficacy Scale and other patient-reported outcome measurements.Results：UW-SES has excellent psychometric properties including well-functioning response categories，no floor effects，and low ceiling effects.有一份长表（17项）和一份短表（6项）。新开发的量表和慢性病自我效能量表的得分之间的相关性很高（.83），为收敛效度提供了支持。更高的自我效能感得分与更好的心理健康，更好的身体健康，减少疲劳，减少压力，减少疼痛干扰，减少疼痛，减少睡眠问题，降低抑郁症状。结论：UW-SES是一种心理测量健全的工具，用于测量自我效能感，在MS和SCI验证，并可以在这两种情况下使用。长表和短表都是免费提供的。
Amtmann D, Bamer AM, Cook KF, Askew RL, Noonan VK, Brockway JA. University of Washington Self-Efficacy Scale: a new self-efficacy scale for people with disabilities. Arch Phys Med Rehabil 2012;93:1757-65.Objective: To develop a self-efficacy scale for people living with multiple sclerosis (MS) and spinal cord injury (SCI) that can be used across diagnostic conditions.Design: The scale was developed using modern psychometric methods including item response theory. Items were administered at 3 time-points of a longitudinal survey of individuals with MS and SCI.Setting: Survey participants with MS were recruited from the National MS Society, and participants with SCI were recruited from the Northwest Regional Spinal Cord Injury Model System and the Shepherd Center at the Virginia Crawford Research Institute in Atlanta, GA.Participants: Adults aged 18 years and older reporting a definitive diagnosis of MS (N = 473) or SCI (N = 253).Interventions: None.Main Outcome Measures: Evaluation of the new self-efficacy measure called the University of Washington Self-Efficacy Scale (UW-SES) included comparisons with the Chronic Disease Self-Efficacy Scale and other patient-reported outcome measures.Results: UW-SES has excellent psychometric properties including well-functioning response categories, no floor effects, and low ceiling effects. A long form (17 items) and a short form (6 items) are available. The correlation between the score on the newly developed scale and the Chronic Disease Self-Efficacy Scale was high (.83), providing support for convergent validity. Higher self-efficacy scores were statistically significantly associated with better mental health, better physical health, less fatigue, less stress, less pain interference, less pain, fewer sleep problems, and lower depressive symptoms.Conclusions: The UW-SES is a psychometrically sound instrument for measuring self-efficacy, validated in MS and SCI, and can be used across both conditions. Both the long form and the short form are available free of charge.